Mikhail Blagoskonny is a researcher who has specialized in oncology. Oncology is the study of cancer and all that pertains to it. He studied in St. Petersburg, at the first Pavlov University taking an internal medicine at master’s level and later got a Ph.D. in experimental medicine and cardiology. He began his work, in 2002, as an associate professor of medicine at the New York medical college. He would later accept a job offer as a senior research scientist at the Ordway research institute in Albany. He only left the Ordway Institute much later in 2009. This occurred after he was given a position at the Rosewell Park Cancer Institute as a professor of oncology. A position he continues to hold till present. Mikhail has published many scholarly articles and as such has found himself as the editor-in-chief of publications platforms such as Aging, Cell Cycle, and Oncotarget. He is also a member of the Cell Death & Differentiation editorial board. Mr.Blagoskonny also doubles in philanthropy by championing for the availability of proper treatment despite an individual’s liquidity and more information click here.
As a professor of oncology, Mr. Blagoskonny has put a lot of effort into the medical research field primarily focusing on cancer and how it’s connected to aging. He is particularly interested in the connection between cancerous conditions and why they mostly occur among older people who are above a certain age. These research areas, touching on cancer and its relationship to aging, have attracted the attention of many scholarly individuals within the medical sphere and learn more about Mikhail.
Mr. Blagoskonny postulates that there is a role played by TOR signaling in aging and cancer. He believes that rapamycin has anti-aging capabilities and proposes it to be used as a life extension tool. He is researching the possibility of rapamycin slowing down the aging process besides tackling cancer cells in cancer patients. He argues against a paper written by Nef, Erhinger, and others who claim that rapamycin can increase a life span but not affect aging. If by increasing life span, rapamycin reduces the risk of death then in retrospect it slows down aging by pushing it further away.
Cancer therapy is very painful and is usually very costly. For a long time, the less able have had to succumb to cancer due to lack of adequate finances for treatment. Mr. Blagoskonny intends to find a method with which cancer can be eradicated, from a sick patient, in a way that will be both inexpensive and rather painless compared to most if not all present day methods. His research aims at finding an alternative that will eradicate cancer cells from the body while preserving healthy cells, unlike the current methods where all cells adversely affected during therapy. These healthy cells are especially necessary when recovering after long durations of cancer treatment.
Mr. Blagoskonny as a leader and professor has inspired many of his students and his peers who have picked up where he leaves. He hopes that more will do the same to help in achieving the dream where cancer therapy will be an easily available treatment and not the luxurious service it has been made out to be and Mikhail’s lacrosse camp.
More Visit: https://www.linkedin.com/in/mikhail-blagosklonny-91abb531/
Mikhail Blagosklonny is an oncologist and a distinguished researcher in the fields of cancer and aging. A native of Russia, he earned his Ph.D. in Experiemental Medicine and Cardiology at First Pavlov State Medical Universtiy in St. Petersburg, before settling in the United States to begin his career at New York Medical College in Valhalla, New York. He was more recently Professor of Oncology at the Roswell Park Cancer Institute in Buffalo, NY and has been an associate editor for PLOS ONE< the American Journal Of Pathology and International Journal Of Cancer. Dr. Blagosklonny is the current editor-in-chief of peer reviewed weekly medical journal Oncotarget, a publication focused on oncology research.
Dr. Blagosklonny has spent much of his career driven by a love of humanity and a belief that disease and aging can be conquered. Much of his research has focused on cell death and common factors in cancer and aging. Dr. Blagosklonny has long observed similarities in the death and decay of cells during the normal aging process and the spread of cancerous disease. He has learned from his studies that just as we can now fight and often conquer cancer, we can also use medical research and discovery to slow and even reverse the aging process, leading to increased longevity and less pain and discomfort in the aging process. Follow Mikhail on Google Scholar
Dr. Mikhail Blagosklonny has gotten much acclaim for his groundbreaking hypothesis concerning common factors in both aging and cancer that may be treatable by similar means. He has spent many years exploring these similarities and believes that just as the same processes may cause cell death and deterioration, the treatments that can reverse the cancer process may well help to halt and reverse the aging process. As a result of his research, Dr. Blagosklonny has proposed the use of popular cancer treatment Rapamycin to help slow or reverse cell death and slow the aging process.
Dr. Blagosklonny has spent many years in the field of oncology and believes that cancer is not only curable, but can, through proper research, become easier and less costly to treat. Current cancer treatments focus on destruction of cancerous cells and as such are often excruciating for the patient and prohibitively expensive. Dr. Blagosklonny believes that by shifting focus to preserving healthy cells and finding less destructive ways to eliminate cancerous growths, cancer patients will be healthier and less uncomfortable during the treatment process, leading to quicker recovery and less costly treatment. With quicker recovery times, fewer lost work houes and less physical deterioration after treatment, Dr. Blagosklonny envisions that cancer treatment will shift from a luxury to a disorder that is simpler and more cost effective to treat. Visit classroomvoices.org to read more about Mikhail.
While Dr. Blagosklonny continues to focus most of his research on cancer and the aging process, which are his areas of medical expertise, he dreams of a world which is entirely disease free. This is what led him into the field of medicine and this vision is what motivates him to continue to pursue new innovations.